Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 11:10 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 601–624 of 7,882 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Non intervention study Clear all

Conditions: Bicep Tendinitis, Biceps; Tenosynovitis, Bicipital Tendinitis, Left Shoulder, Bicipital Tendinitis, Right Shoulder, Bicipital Tendinitis, Unspecified Shoulder, Biceps Tendon Disorder
Interventions: Dry Needling, Heavy Slow Load Exercise, Rotator cuff and scapular stabilization exercise program, Soft tissue mobilization; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 64 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 2
States / cities: Aurora, Colorado • Boulder, Colorado

Conditions: Anxiety
Interventions: Cognitive Behavioral Therapy; Behavioral
Lead sponsor: The Cleveland Clinic; Other
Eligibility: Not listed
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2017
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Suicide, Suicide, Attempted, Suicidal Ideation
Interventions: DBT Online Program; Behavioral
Lead sponsor: Kaiser Permanente; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Stage I Colon Cancer, Stage I Rectal Cancer, Stage IA Non-small Cell Lung Cancer, Stage IB Non-small Cell Lung Cancer, Stage IIA Colon Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIA Rectal Cancer, Stage IIB Colon Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIB Rectal Cancer, Stage IIC Colon Cancer, Stage IIC Rectal Cancer, Stage IIIA Colon Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIA Rectal Cancer, Stage IIIB Colon Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IIIB Rectal Cancer, Stage IIIC Colon Cancer, Stage IIIC Rectal Cancer
Interventions: educational intervention, questionnaire administration, quality-of-life assessment; Other · Procedure
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 21 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 1
States / cities: Duarte, California

Conditions: Chronic Nausea, Anxiety
Interventions: Inhaled Essential Oils, Wearable TENS Device; Other · Device
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Cardiovascular (CV) Risk
Interventions: Lion Hearts Family-Based Physical Activity Program; Behavioral
Lead sponsor: Penn State University; Other
Eligibility: 10 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: State College, Pennsylvania

Conditions: Pain, Depressive Symptoms, Frailty, Aging
Interventions: DAPPER; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 50 Years and older · Female only
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Cannabis Use, Drug Use, Development, Infant
Interventions: No Intervention will be used; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 40 Years
Enrollment: 92 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Pelvic Ring Fractures
Interventions: Miacalcin Calcitonin Salmon Nasal Spray; Drug
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 65 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: SARS-CoV-2 Infection
Interventions: Convalescent Plasma (anti-SARS-CoV-2 plasma), Non-convalescent Plasma (control plasma); Biological
Lead sponsor: Max O'Donnell; Other
Eligibility: 18 Years and older
Enrollment: 223 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Obesity, Fruit and Vegetable Intake, Healthy Diet
Interventions: Real-Time Incentives Group; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 244 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Mental Health, Suicide
Interventions: Messaging, Wait list control; Behavioral · Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 89 Years
Enrollment: 355 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Canandaigua, New York

Conditions: Recurrent Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
Interventions: cytology specimen collection procedure, laboratory biomarker analysis; Other
Lead sponsor: Barbara Ann Karmanos Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 619 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2027
U.S. locations: 11
States / cities: Bay City, Michigan • Bloomfield Hills, Michigan • Clarkston, Michigan + 8 more

Conditions: Cancer
Interventions: vorinostat; Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2008
U.S. locations: 1
States / cities: New York, New York

Conditions: Multiple Myeloma
Interventions: Non-Interventional Study; Other
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 700 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 11
States / cities: Goodyear, Arizona • Duarte, California • Huntington Beach, California + 8 more

Conditions: Cancer, Psychological Distress, Adaptation, Psychological
Interventions: SHINE Psychosocial Intervention, Usual Supportive Care; Behavioral
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 10 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Message Exposure (Sequence: Regular Then Flavor), Message Exposure (Sequence: Flavor Then Regular), No Message Exposure (Control Condition)
Interventions: Exposure to Anti-Vaping Messages (generic themes then flavor-specific themes), Exposure to Anti-Vaping Messages (flavor-specific themes then generic themes), Exposure to Anti-Vaping Messages (no message exposure); Behavioral
Lead sponsor: University of Georgia; Other
Eligibility: 18 Years to 29 Years
Enrollment: 180 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Athens, Georgia

Conditions: Diabetes
Interventions: team-based care; Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Systemic Lupus Erythematosus
Interventions: Tofacitinib, Placebo; Drug
Lead sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); NIH
Eligibility: 18 Years to 100 Years
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Lymphoma, Multiple Myeloma, Non-Hodgkin Lymphoma, Relapsed Hodgkin's Disease, Adult
Interventions: Isatuximab, Standard Procedures; Drug · Other
Lead sponsor: Divaya Bhutani; Other
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 2
States / cities: Detroit, Michigan • New York, New York

Conditions: Medical Abortion
Interventions: Self-assessment; Behavioral
Lead sponsor: Gynuity Health Projects; Other
Eligibility: 11 Years to 56 Years · Female only
Enrollment: 343 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 3
States / cities: West Palm Beach, Florida • Chevy Chase, Maryland • Philadelphia, Pennsylvania

Conditions: Chronic Periodontitis, Type 2 Diabetes
Interventions: Non-surgical periodontal therapy, Delayed non-surgical periodontal therapy; Procedure · Other
Lead sponsor: Stony Brook University; Other
Eligibility: 35 Years and older
Enrollment: 514 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 8
States / cities: Birmingham, Alabama • Minneapolis, Minnesota • Stony Brook, New York + 2 more

Conditions: Chronic Kidney Disease, Type 2 Diabetes
Interventions: Finerenone, Semaglutide, Lotensin, Capoten, Enalapril, Monopril, Lisinopril, Univasc, Aceon, Accupril, Altace, Mavik, Edarbi, Atacand, Avapro, Cozaar, Benicar, Micardis, Diovan, Invokana, Farxiga, Jardiance, Ertugliflozin, Brenzavvy, Sotagliflozin; Drug
Lead sponsor: Baylor Research Institute; Other
Eligibility: 18 Years to 84 Years
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Temple, Texas

Conditions: Cellulite
Interventions: Avéli device; Device
Lead sponsor: Revelle Aesthetics, Inc; Industry
Eligibility: 21 Years to 55 Years · Female only
Enrollment: 74 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 7
States / cities: Los Angeles, California • San Diego, California • San Francisco, California + 4 more

Search by objective public record fields.

Dry Needling and Exercise Versus Traditional Physical Therapy for Biceps Tendinitis

Interventional Study of Anxiety Symptoms in the Implantable Cardioverter Defibrillator (ICD) Patient

Now Matters Now: An Online Suicide Prevention Program

Survivorship Care Planning in Patients With Colorectal or Non-Small Cell Lung Cancer

AROMA-NT: Essential Oils and Wearable TENS Device for Chronic Nausea

Lions Hearts: A Community Approach to Multigenerational Cardiovascular Disease Risk

Depression and Pain Perseverance Through Empowered Recovery Intervention

Intergenerational Effects of Paternal Periconceptional Cannabis and Other Drug Use (EPIC)

The Use of Intranasal Calcitonin to Improve Pain and Activity in Elderly Pelvic Ring Injuries

Plasma Therapy of COVID-19 in Severely Ill Patients

Fruits and Vegetables Incentives Study

Public Messaging to Increase Treatment Seeking for Veterans at Risk for Suicide

Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer

Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer

A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients

Support and Healing Intervention for Adolescents With a Parent Diagnosed With Cancer (SHINE)

Neuroimaging Approaches to Improve Prediction of Smoking Initiation and Nicotine Escalation in Young Adult ENDS Users

Comprehensive Intervention to Evaluate Outcomes AND Cost in Hospitalized Surgical Patients With Diabetes Mellitus (DM)

Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Systemic Lupus Erythematosus

Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and Lymphoma

Self-Assessment of Medical Abortion Outcome Using Serial Multi-level Pregnancy Tests

Diabetes and Periodontal Therapy Trial

Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)

CONtrolled Focal Fibrous Band Release Method Study